- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
You are here
Trial Search
| Trial Name | Prevention Option | Phase | Start Date | Sponsors | Countries | Population | Candidate(s) | Status |
|---|---|---|---|---|---|---|---|---|
| Cabotegravir implant (Preclinical) | Microbicides, PrEP | Pre-clinical | NIAID | United States of America | Men | Cabotegravir (GSK 744) | Completed | |
| 90-day Pod-type Etonogestrel/Ethinyl Estradiol/QGriffithsin (QGRFT) Intravaginal Ring [EEQ IVR] | Microbicides | Pre-clinical | April 2020 | NIAID | Q-GRFT | Ongoing | ||
| CLIP Ring | Microbicides, Multipurpose Prevention Technologies | Pre-clinical | December 2019 | CDC, NIAID | Men | Islatravir (MK-8591) | ||
| Amphora/QGriffithsin (QGRFT) fast-dissolving vaginal insert (FDI) | Microbicides | Pre-clinical | May 2021 | NIAID | Q-GRFT | |||
| mAb 2C7 + TDF IVR | Microbicides | Open Label | April 2018 | Men | TDF | Ongoing | ||
| Novel mAb contraceptive + TDF IVR | Microbicides | Pre-clinical | May 2020 | NICHD | TDF | Ongoing | ||
| PREVENT study | Microbicides | I | July 2019 | Rhonda Brand; NIAID; Intrucept Biomedicine LLC | Men, Women | Q-GRFT | ||
| FAME103 | Microbicides | I | August 2020 | NIAID (STUDY19100120) | United States of America | Women | MK-2048 | Ongoing |
| Pop Council PC-6500 Vaginal insert | Microbicides | I | March 2018 | Women | PC-6500 | |||
| CONRAD B17-144 | Microbicides, Multipurpose Prevention Technologies | II | December 2018 | Kenya | Women | TFV/LNG ring, TFV ring | Ongoing | |
| CONRAD A15-140 | Microbicides, PrEP | I | April 2016 | United States of America | Women | TFV ring, TDF/FTC (Truvada) | Completed | |
| CONRAD A15-138/ ENRICH | Microbicides, Multipurpose Prevention Technologies | I | September 2017 | CONRAD | United States of America, Dominican Republic | Men | TFV/LNG ring | Completed |
| Population Council #728 | Microbicides | I | October 2017 | United States of America | Women | PC-6500 | Completed | |
| Population Council #558 | Microbicides, Multipurpose Prevention Technologies | I | May 2014 | Population Council | United States of America | Women | PC-1005 gel, HEC gel | Completed |
| OB-002H | Microbicides | I | October 2019 | SCOPE International AG | Poland | MSM, Women | Completed | |
| CONRAD A18-146 | Microbicides, Multipurpose Prevention Technologies | I | December 2018 | CONRAD | United States of America | Women | Elvitegravir (EVG), F/TAF | Completed |
| ImQuest DuoGel | Microbicides | I | November 2017 | United States of America | Men, Women | IQP-0528 | Completed | |
| MTN-041/ MAMMA | Microbicides, PrEP | Other | May 2018 | NIAID (DAIDS-ES: 38161) | Malawi, South Africa, Uganda, Zimbabwe | Women | Dapivirine Ring, TDF/FTC (Truvada) | Ongoing |
| MTN 043/ B-PROTECTED | Microbicides | Open Label, III | August 2020 | NIAID (DAIDS-ES: 38591) | Malawi, South Africa, Uganda, Zimbabwe | Adolescent/Children, Lactating women, Women | Dapivirine Ring, TDF/FTC (Truvada) | Completed |
| MTN-044/IPM 053/ CCN019 | Microbicides, Multipurpose Prevention Technologies | Open Label, I | July 2018 | United States of America | Women | Dapivirine-Levonorgestrel ring | Completed |
Pages
